Tuesday, 22 March 2016 06:34

Valued Quality of Care Coordination: Chronic Care Differential

Written by


This is the fifth article in a series addressing the value proposition of long-term, post-acute care (LTPAC) providers and health IT vendors. The articles focus on five major valued quality of care coordination (VQCC) differentials between LTPAC providers and acute/ambulatory care providers. This series of articles is based on the LTPAC health IT collaborative ONC brief written in May 2015 for Karen B. DeSalvo, national coordinator for health information technology and acting assistant secretary for health with the U.S. Department of Health and Human Services (HHS), titled Health Information Technology Use & Value Delivered by The Long-Term and Post-Acute Care (LTPAC) Sector.

Readers can find the complete ONC brief on the LTPAC HIT Collaborative website.

The following is a summary table of the five VQCC differentials cited in the ONC brief. Articles have been published on the first two differentials (duration and e-assessments).

This article is about what might be the most important VQCC differential: chronic care comorbidities. Why is chronic care the most important of the five differentials? The major reasons are:

An aging population: The fact that the Medicare program has experienced a large influx of new enrollees during recent years isn’t new news. What might be new is the anticipated rapid future growth of the program’s enrollees in their early to mid-80s. Mark Parkinson, MD, president and CEO of the American Health Care Association (AHCA), noted in a recent speech at the Direct Supply DSSI Forum in February that this age group had flat growth from 2012-2015. This caused a census issue in skilled nursing facilities (SNFs). As you can see from the graph, after 2015 and through 2030, the number of people over 80 is projected to increase at a rapid rate. This group includes the elderly, who are most prone to requiring chronic care.

Prev Next »

Last modified on Tuesday, 24 May 2016 17:44

John F. Derr, RPh is CEO of JD & Associates Enterprises specializing in Strategic Clinical Technology with a focus on person centric electronic longitudinal medication management and LTPAC. He has over fifty years of top executive level experience Squibb, Siemens, Tenet (NME), Kyocera, MediSpan and EVP of AHCA. He was SVP, CIO and CTO for Golden Living, LLC. He is a member of Corporate Boards providing guidance on clinical Health IT and medication management. He represents LTPAC and Pharmacy as a member of HHS HITECH Committee on Standards. Derr is a graduate of Purdue School of Pharmacy and a 2006 Distinguished Purdue Alumnus.